Arcutis Biotherapeutics (ARQT) Gets New Rating Uprgades from 2 Analysts; Shares Climb

Arcutis Biotherapeutics (NASDAQ:ARQT) saw its share price jump by 10.65 percent to close at $31.89 apiece after earning a bullish outlook and a double-digit price target hike from an analyst. In its market note, investment firm Guggenheim upgraded its stock target by 15.8 percent to $44 from $38 previously, while keeping a buy recommendation. It […]